BRIANA ASPY: Open Payments
NPI 1750545414 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 19 payments from 8 companies in 2025. Trend: 2023 $511 · 2024 $426 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $152 |
| Novo Nordisk Inc | 2 | $58 |
| Corcept Therapeutics | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: LINZESS, Wegovy, Korlym, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Cologuard Collection Kit, TZIELD, Tirosint.
Industry payments across IN — which companies pay providers there.
